{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T12:19:21Z","timestamp":1772367561844,"version":"3.50.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.gastrohep.2022.02.005","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T19:07:30Z","timestamp":1646334450000},"page":"724-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)"],"prefix":"10.1016","volume":"45","author":[{"given":"Roc\u00edo","family":"Gallego-Dur\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agust\u00edn","family":"Albillos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Ampuero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Arechederra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Ba\u00f1ares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Blas-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genoveva","family":"Bern\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Caparr\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa C.","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Manuel","family":"Falc\u00f3n-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n","family":"Franc\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maite G.","family":"Fern\u00e1ndez-Barrena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Graupera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Iruzubieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulia A.","family":"Nevzorova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rub\u00e9n","family":"Nogueiras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo I.R.","family":"Mac\u00edas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Sabio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germ\u00e1n","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Vaquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Javier","family":"Cubero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7736-4089","authenticated-orcid":false,"given":"Jordi","family":"Gracia-Sancho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2022.02.005_bib0495","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0500","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain United Kingdom, and United States for the period 2016\u20132030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0505","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0510","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jhep.2020.02.028","article-title":"HEPAmet Registry. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH","volume":"73","author":"Ampuero","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0515","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.cgh.2019.02.045","article-title":"Crohn's disease is associated with an increased prevalence of nonalcoholic fatty liver disease: a cross-sectional study using magnetic resonance proton density fat fraction mapping","volume":"17","author":"McHenry","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0520","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/apt.14910","article-title":"Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factors","volume":"48","author":"Tovoli","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0525","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1111\/jdv.15764","article-title":"High prevalence of non-alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors","volume":"33","author":"Dur\u00e1n-Vian","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0530","doi-asserted-by":"crossref","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0535","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41574-020-00418-5","article-title":"The role of stress kinases in metabolic disease","volume":"16","author":"Nikolic","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0540","doi-asserted-by":"crossref","first-page":"572089","DOI":"10.3389\/fendo.2020.572089","article-title":"Uncovering the role of p38 family members in adipose tissue physiology","volume":"11","author":"Leiva","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0545","doi-asserted-by":"crossref","first-page":"101190","DOI":"10.1016\/j.molmet.2021.101190","article-title":"Stress kinases in the development of liver steatosis and hepatocellular carcinoma","volume":"50","author":"Cicu\u00e9ndez","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0550","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0555","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0560","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/s41467-019-09455-9","article-title":"A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease","volume":"10","author":"Caussy","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0565","article-title":"Decompensation in advanced nonalcoholic fatty liver disease may occur at lower hepatic venous pressure gradient levels than in patients with viral disease","author":"Bassegoda","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0570","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2020.10.003","article-title":"Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis","volume":"74","author":"Ferrusqu\u00eda-Acosta","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0575","article-title":"Baveno VII \u2013 renewing consensus in portal hypertension: report of the Baveno VII Consensus Workshop: personalized care in portal hypertension","author":"de Franchis","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0580","doi-asserted-by":"crossref","first-page":"e190047","DOI":"10.1001\/jamanetworkopen.2019.0047","article-title":"Cost-effectiveness analysis of bariatric surgery for patients with nonalcoholic steatohepatitis cirrhosis","volume":"2","author":"Klebanoff","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0585","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-G\u00f3mez","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0590","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jhep.2019.07.026","article-title":"Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease","volume":"71","author":"Abu Dayyeh","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0595","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2016.04.018","article-title":"Sinusoidal communication in liver fibrosis and regeneration","volume":"65","author":"Marrone","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0600","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-020-00411-3","article-title":"Role of liver sinusoidal endothelial cells in liver diseases","volume":"18","author":"Gracia-Sancho","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0605","doi-asserted-by":"crossref","first-page":"100145","DOI":"10.1016\/j.jhepr.2020.100145","article-title":"Nuclear deformation mediates liver cell mechanosensing in cirrhosis","volume":"2","author":"Guix\u00e9-Muntet","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0610","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10620-017-4903-5","article-title":"Origins of portal hypertension in nonalcoholic fatty liver disease","volume":"63","author":"Baffy","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0615","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2021.09.029","article-title":"Overlooked subclinical portal hypertension in non-cirrhotic NAFLD: is it real and how to measure it?","volume":"76","author":"Baffy","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0620","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.gastro.2018.04.014","article-title":"Magnetic resonance imaging proton density fat fraction associates with progression of fibrosis in patients with nonalcoholic fatty liver disease","volume":"155","author":"Ajmera","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0625","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.29797","article-title":"Noninvasive quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0630","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0635","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jhepr.2019.02.004","article-title":"Macrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism","volume":"1","author":"Lefere","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0640","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/jcm10040673","article-title":"Cognitive dysfunction in non-alcoholic fatty liver disease-current knowledge mechanisms and perspectives","volume":"10","author":"Kj\u00e6rgaard","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0645","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"Schuppan","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0650","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jhep.2010.12.017","article-title":"C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients","volume":"55","author":"Zimmermann","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0655","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1389200216666151103115454","article-title":"Bile acids in physiology pathology and pharmacology","volume":"17","author":"Marin","year":"2015","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0660","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/MOL.0000000000000597","article-title":"Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?","volume":"30","author":"Ch\u00e1vez-Talavera","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0665","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1210\/jc.2017-01397","article-title":"Bile acid alterations are associated with insulin resistance, but not with NASH, in obese subjects","volume":"102","author":"Legry","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0670","doi-asserted-by":"crossref","first-page":"100222","DOI":"10.1016\/j.jhepr.2020.100222","article-title":"NASH-related increases in plasma bile acid levels depend on insulin resistance","volume":"3","author":"Grzych","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0675","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41575-018-0097-3","article-title":"Hepatic microcirculation and mechanisms of portal hypertension","volume":"16","author":"Gracia-Sancho","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0680","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0685","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0690","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","article-title":"The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis","volume":"74","author":"Arroyo","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0695","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/gutjnl-2019-318843","article-title":"Albumin in decompensated cirrhosis: new concepts and perspectives","volume":"69","author":"Bernardi","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0700","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jhep.2019.11.009","article-title":"Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF","volume":"72","author":"Moreau","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0705","doi-asserted-by":"crossref","first-page":"154170","DOI":"10.1016\/j.metabol.2020.154170","article-title":"Complications, morbidity and mortality of nonalcoholic fatty liver disease","volume":"111S","author":"Mantovani","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0710","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0715","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2021.04.049","article-title":"Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis","volume":"75","author":"Pinyol","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0720","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0725","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0730","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jhep.2019.06.031","article-title":"Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease","volume":"71","author":"Rosso","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0735","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0740","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","article-title":"The power of plasticity-metabolic regulation of hepatic stellate cells","volume":"33","author":"Trivedi","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0745","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0750","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0755","doi-asserted-by":"crossref","first-page":"e127737","DOI":"10.1172\/jci.insight.127737","article-title":"Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver","volume":"5","author":"Fletcher","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0760","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cmet.2020.01.013","article-title":"Targeting hepatic glutaminase 1 ameliorates non-alcoholic steatohepatitis by restoring very-low-density lipoprotein triglyceride assembly","volume":"31","author":"Simon","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0765","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1038\/s41467-020-16991-2","article-title":"Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation","volume":"11","author":"Barbier-Torres","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0770","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","article-title":"The molecular machinery of regulated cell death","volume":"29","author":"Tang","year":"2019","journal-title":"Cell Res"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0775","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0780","doi-asserted-by":"crossref","first-page":"9682","DOI":"10.3390\/ijms21249682","article-title":"Cell death in liver diseases: a review","volume":"21","author":"Shojaie","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0785","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0790","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0795","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.molimm.2019.01.004","article-title":"Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells","volume":"107","author":"Yu","year":"2019","journal-title":"Mol Immunol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0800","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1038\/s41467-018-06318-7","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"MacParland","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0805","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/hep.31743","article-title":"Heterogeneity of HSCs in a mouse model of NASH","volume":"74","author":"Rosenthal","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0810","doi-asserted-by":"crossref","first-page":"101111","DOI":"10.1016\/j.molmet.2020.101111","article-title":"Genetic and epigenetic factors determining NAFLD risk","volume":"50","author":"Jonas","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0815","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0820","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jhep.2020.04.009","article-title":"Epitranscriptomics in liver disease: basic concepts and therapeutic potential","volume":"73","author":"Zhao","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0825","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/liv.14360","article-title":"The role of nutrition in non-alcoholic fatty liver disease: pathophysiology and management","volume":"40","author":"Bern\u00e1","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0830","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1146\/annurev-nutr-071715-051118","article-title":"Nutritional ecology and human health","volume":"36","author":"Raubenheimer","year":"2016","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0835","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jhep.2017.10.005","article-title":"The nutritional geometry of liver disease including non-alcoholic fatty liver disease","volume":"68","author":"Simpson","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0840","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","article-title":"Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma","volume":"12","author":"Behary","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0845","doi-asserted-by":"crossref","first-page":"e9302","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0850","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1111\/liv.14571","article-title":"Bacterial antigen translocation and age as BMI-independent contributing factors on systemic inflammation in NAFLD patients","volume":"40","author":"G\u00f3mez-Hurtado","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0855","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.3389\/fimmu.2018.01994","article-title":"Cells improve nonalcoholic fatty liver disease through regulating macrophage polarization","volume":"9","author":"Li","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0860","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.cmet.2021.04.018","article-title":"PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease","volume":"33","author":"Moreno-Fernandez","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0865","doi-asserted-by":"crossref","first-page":"107683","DOI":"10.1016\/j.pharmthera.2020.107683","article-title":"Extracellular vesicles in hepatology: physiological role, involvement in pathogenesis, and therapeutic opportunities","volume":"218","author":"Azparren-Angulo","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0870","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/hep4.1642","article-title":"Molecular profiling of decompensated cirrhosis by a novel microRNA signature","volume":"5","author":"Garcia Garcia de Paredes","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0875","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.7150\/ijbs.59725","article-title":"Could protein content of urinary extracellular vesicles be useful to detect cirrhosis in alcoholic liver disease?","volume":"17","author":"Gonzalez","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0880","doi-asserted-by":"crossref","first-page":"836","DOI":"10.4161\/rna.29305","article-title":"Sorting signal targeting mRNA into hepatic extracellular vesicles","volume":"11","author":"Szostak","year":"2014","journal-title":"RNA Biol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0885","doi-asserted-by":"crossref","first-page":"42798","DOI":"10.1038\/srep42798","article-title":"Hepatocyte-secreted extracellular vesicles modify blood metabolome and endothelial function by an arginase-dependent mechanism","volume":"7","author":"Royo","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0890","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0895","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mam.2016.11.008","article-title":"Epigenetics in non-alcoholic fatty liver disease","volume":"54","author":"Lee","year":"2017","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0900","doi-asserted-by":"crossref","first-page":"154320","DOI":"10.1016\/j.metabol.2020.154320","article-title":"The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease","volume":"111S","author":"Perakakis","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0905","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cmet.2019.12.002","article-title":"Leveraging human genetics to identify potential new treatments for fatty liver disease","volume":"31","author":"Romeo","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0910","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0915","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000443344","article-title":"Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease","volume":"9","year":"2016","journal-title":"Obes Facts"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0920","doi-asserted-by":"crossref","first-page":"732929","DOI":"10.3389\/fphys.2021.732929","article-title":"Liver zonation \u2013 revisiting old questions with new technologies","volume":"12","author":"Cunningham","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0925","doi-asserted-by":"crossref","first-page":"730008","DOI":"10.3389\/fbioe.2021.730008","article-title":"Human three-dimensional hepatic models: cell type variety and corresponding applications","volume":"9","author":"Xu","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0930","doi-asserted-by":"crossref","first-page":"100198","DOI":"10.1016\/j.jhepr.2020.100198","article-title":"Organoids to model liver disease","volume":"3","author":"Nuciforo","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0935","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/jcm10010036","article-title":"In vitro and in vivo models of non-alcoholic fatty liver disease: a critical appraisal","volume":"10","author":"Soret","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0940","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hep4.1647","article-title":"Human nonalcoholic steatohepatitis on a chip","volume":"5","author":"Freag","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0945","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.30651","article-title":"A bioreactor technology for modeling fibrosis in human and rodent precision-cut liver slices","volume":"70","author":"Paish","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0950","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jhep.2020.04.011","article-title":"Animal models for liver disease \u2013 a practical approach for translational research","volume":"73","author":"Nevzorova","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0955","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3390\/biomedicines9101289","article-title":"Fat: quality, or quantity? What matters most for the progression of Metabolic Associated Fatty Liver Disease (MAFLD)","volume":"9","author":"Est\u00e9vez-V\u00e1zquez","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0960","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/hep4.1698","article-title":"An experimental DUAL model of advanced liver damage","volume":"5","author":"Bened\u00e9-Ubieto","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0965","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3390\/cells8091062","article-title":"New rat model of advanced NASH mimicking pathophysiological features and transcriptomic signature of the human disease","volume":"8","author":"Maeso-D\u00edaz","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0970","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12967-018-1678-1","article-title":"Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail","volume":"16","author":"Pound","year":"2018","journal-title":"J Transl Med"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0975","doi-asserted-by":"crossref","first-page":"e0218014","DOI":"10.1371\/journal.pone.0218014","article-title":"A standardised framework to identify optimal animal models for efficacy assessment in drug development","volume":"14","author":"Ferreira","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.gastrohep.2022.02.005_bib0980","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/hep.30333","article-title":"Mouse models of nonalcoholic steatohepatitis: toward optimization of their relevance to human nonalcoholic steatohepatitis","volume":"69","author":"Farrell","year":"2019","journal-title":"Hepatology"}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570522000796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570522000796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:46:10Z","timestamp":1759322770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570522000796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":98,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0210570522000796"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2022.02.005","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2022.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}